SMAD3 and early-onset autosomal dominant Alzheimer disease: We analyzed existing blood SMAD3 expression, genetic and imaging data from two longitudinal antemortem cohorts, Mayo Clinic Study of Aging (MCSA)75 and Alzheimer’s Disease Neuroimaging Initiative (ADNI)76.